4
Changes in Ownership
TriSalus Life Sciences, Inc. Filed Acc 0001628280-26-020186
CEO and President sold 20,302 shares at an average $3.91 ($79,383)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Szela Mary T CEO and President | 2026-03-11 | Sale | −4,358 | $4.13 | $17,999 | 768,931 | D |
| Szela Mary T CEO and President | 2026-03-17 | Sale | −15,944 | $3.85 | $61,384 | 752,987 | D |
| Open-market sales · 20,302 sh · avg $3.91 · $79,383 | |||||||
Loading xslF345X06/wk-form4_1774038323.xml…